Suppr超能文献

肾细胞癌的pT2分类。其准确性能否提高?

pT2 classification for renal cell carcinoma. Can its accuracy be improved?

作者信息

Frank Igor, Blute Michael L, Leibovich Bradley C, Cheville John C, Lohse Christine M, Kwon Eugene D, Zincke Horst

机构信息

Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA.

出版信息

J Urol. 2005 Feb;173(2):380-4. doi: 10.1097/01.ju.0000149937.75566.ac.

Abstract

PURPOSE

The 2002 tumor classification for renal cell carcinoma (RCC) classifies pT2 tumors as more than 7 cm in greatest dimension, limited to the kidney. In this study we determined whether a size cutoff point exists within pT2 tumors and whether such subclassification would further improve the accuracy of the current tumor classification.

MATERIALS AND METHODS

We studied 544 patients with unilateral, sporadic pT2 RCC treated with radical nephrectomy or nephron sparing surgery between 1970 and 2000. The association of tumor size with death from RCC was examined using martingale residuals from a Cox proportional hazards regression model to determine the optimal size cutoff point.

RESULTS

There were 204 deaths from RCC a median of 3.8 years following nephrectomy. Univariately tumor size was significantly associated with death from RCC (risk ratio 1.08, 95% CI 1.04 to 1.13, p <0.001). A scatterplot of tumor size vs expected risk of death per patient suggested that a cutoff point between 9 and 10 cm was appropriate. When adjusted for regional lymph node involvement and distant metastases, the 10 cm cutoff point performed better than the 9 cm point (risk ratio 1.42, 95% CI 1.07 to 1.90, p = 0.017 vs 1.22, 95% 0.86 to 1.72, p = 0.268). Therefore, we propose using a 10 cm cutoff point to subclassify patients into pT2a and pT2b.

CONCLUSIONS

Our data suggest that the prognostic accuracy of the 2002 pT2 tumor classification can be further improved by subclassifying patients with tumors greater than 7 and less than 10 cm into a pT2a category, and those with tumors 10 cm or greater into a pT2b category.

摘要

目的

2002年肾细胞癌(RCC)肿瘤分类将pT2肿瘤定义为最大径大于7 cm且局限于肾脏。在本研究中,我们确定pT2肿瘤内是否存在一个大小分界点,以及这种亚分类是否会进一步提高当前肿瘤分类的准确性。

材料与方法

我们研究了1970年至2000年间接受根治性肾切除术或保留肾单位手术治疗的544例单侧、散发性pT2肾细胞癌患者。使用Cox比例风险回归模型的鞅残差来检验肿瘤大小与肾细胞癌死亡之间的关联,以确定最佳大小分界点。

结果

肾切除术后中位3.8年,有204例患者死于肾细胞癌。单因素分析显示,肿瘤大小与肾细胞癌死亡显著相关(风险比1.08,95%可信区间1.04至1.13,p<0.001)。肿瘤大小与每位患者预期死亡风险的散点图表明,9至10 cm之间的分界点是合适的。在调整区域淋巴结受累和远处转移因素后,10 cm分界点的表现优于9 cm分界点(风险比1.42,95%可信区间1.07至1.90,p = 0.017;相比之下,1.22,95%可信区间0.86至1.72,p = 0.268)。因此,我们建议使用10 cm分界点将患者亚分类为pT2a和pT2b。

结论

我们的数据表明,对于2002年pT2肿瘤分类,将肿瘤大于7 cm且小于10 cm的患者亚分类为pT2a类别,将肿瘤10 cm或更大的患者亚分类为pT2b类别,可以进一步提高预后准确性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验